e-Profile Login and ID Quick Search
New Jersey to Implement PMP
The state of New Jersey has contracted a company to develop and implement its prescription monitoring program (PMP) system. A law requiring a PMP in the state was adopted in 2008 and the state received a federal grant of $350,000 under the Harold Rogers Prescription Monitoring Program to support the initial year of operating the system. To plan for implementation of the PMP, the Division of Consumer Affairs began meeting to discuss regulations and rules for implementing the PMP. New Jersey’s law allows drugs of concern to be added to the list of prescriptions that must be monitored. Acting director of the Division of Consumer Affairs, Thomas Calcagni, included growth hormone as a drug of concern in the draft regulations, as reported by The Star Ledger. Information about the misuse of allegedly illegally prescribed growth hormone and anabolic steroids by a large number of New Jersey law enforcement officers and firefighters drew attention to misuse of these drugs and the need for a PMP in December 2010.
